| Literature DB >> 22872695 |
Lindy Clemson1, Maria A Fiatarone Singh, Anita Bundy, Robert G Cumming, Kate Manollaras, Patricia O'Loughlin, Deborah Black.
Abstract
OBJECTIVES: To determine whether a lifestyle integrated approach to balance and strength training is effective in reducing the rate of falls in older, high risk people living at home.Entities:
Mesh:
Year: 2012 PMID: 22872695 PMCID: PMC3413733 DOI: 10.1136/bmj.e4547
Source DB: PubMed Journal: BMJ ISSN: 0959-8138

Flow chart of trial participants. *Requested to discontinue the exercise programme; does not include some participants who were not exercising in the final month (LiFE, n=10; structured, n=18; control, n=19)
Demographic and health status of trial participants at baseline. Data are no (%) of participants unless stated otherwise
| LiFE programme (n=107) | Structured exercise (n=105) | Control (gentle exercise) (n=105) | |
|---|---|---|---|
| Age (years; mean (SD)) | 82.81 (4.48) | 84.03 (4.38) | 83.47 (3.81) |
| Female sex | 59 (55.1) | 57 (54.3) | 58 (55.2) |
| No of falls in past year (mean (SD)) | 2.13 (1.47) | 2.21(1.80) | 2.07 (1.10) |
| Injurious falls in past year | 101 (94) | 96 (91) | 93 (89) |
| History of stroke | 14 (13) | 14 (13) | 11 (11) |
| Has chronic illness | 63 (35) | 59 (33) | 59 (33) |
| Hospital admissions past year | 41 (38) | 37 (35) | 50 (47) |
| No of drugs prescribed (mean (SD)) | 5.5 (3.7) | 5.4 (2.8) | 4.6 (2.8) |
| Geriatric depression scale score (mean (SD)) | 5.9 (3.7) | 6.4 (4.0) | 6.2 (3.9) |
SD=standard deviation.
Balance outcomes
| LiFE programme | Structured programme | Control programme | Comparison of all three groups*† | Pairwise comparison of LiFE | Effect size | Pairwise comparison of structured | Effect size | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Mean score (standard deviation) | N | Mean score (standard deviation) | N | Mean score (standard deviation) | ||||||||
| Baseline | 107 | 47.1 (26.9) | 105 | 51.8 (26.7) | 105 | 51.3 (27.4) | F(4,442)=5.10; P=0.001‡; n=71, 75, 78 | F(2,294)=6.6; P=0.002‡ | 0.42 | F(2,302)=8.9; P<0.0001‡ | 0.49 | ||
| 6 months | 81 | 26.0 (20.0) | 85 | 31.9 (23.7) | 82 | 40.7 (24.0) | |||||||
| 12 months | 76 | 33.7 (31.5) | 76 | 38.8 (34.6) | 82 | 54.4 (38.1) | |||||||
| Baseline | 107 | 3.07 (1.08) | 105 | 3.00 (1.15) | 105 | 3.44 (0.96) | n=76, 76, 82 | Odds ratio 1.10 (95% CI 0.47 to 1.72), wald 11.9§; P=0.001 | 0.55 | Odds ratio 0.62 (95% CI 0.03 to 1.22), wald 4.26§; P=0.04 | 0.33 | ||
| 6 months | 81 | 3.44 (0.96) | 85 | 3.14 (1.09) | 82 | 3.21 (0.93) | |||||||
| 12 months | 76 | 3.54 (0.79) | 76 | 3.28 (1.00) | 82 | 2.98 (1.07) | |||||||
| Baseline | 107 | 3.97 (2.06) | 105 | 3.82 (2.03) | 105 | 3.90 (2.00) | n=76, 76, 82 | Odds ratio 1.15 (95% CI 0.58 to 1.72), wald 15.6§; P<0.0001 | 0.63 | Not significant (P=0.08) | 0.29 | ||
| 6 months | 79 | 5.18 (1.99) | 84 | 4.43 (2.22) | 82 | 4.34 (2.08) | |||||||
| 12 months | 76 | 5.17 (1.96) | 76 | 4.54 (2.09) | 82 | 3.88 (2.12) | |||||||
*Main effect time×intervention: F(df, error)=measure of variation between groups divided by variation within groups; P value.
†No of participants in LiFE, structured exercise, and control groups, respectively.
‡Skewed data transformed before analysis.
§Polynomial regression model used with rank order categorical data.
Strength outcomes
| LiFE programme | Structured programme | Control programme | Comparison of all three groups*† | Pairwise comparison of LiFE | Effect size | Pairwise comparison of structured | Effect size | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Mean score (standard deviation) | N | Mean score (standard deviation) | N | Mean score (standard deviation) | ||||||||
| Baseline | 107 | 11.7 (4.8) | 105 | 12.1 (5.2) | 104 | 11.9 (4.3) | F(3.8,399)=2.66‡; P=0.035; n=68, 71, 75 | F(2,282)=5.5; P=0.005 | 0.40 | Not significant (P=0.10) | 0.26 | ||
| 6 months | 81 | 13.5 (5.0) | 82 | 12.9 (5.0) | 82 | 12.3 (4.8) | |||||||
| 12 months | 72 | 13.8 (4.8) | 74 | 13.1 (5.5) | 80 | 12.3 (5.2) | |||||||
| Baseline | 107 | 11.4 (4.5) | 105 | 12.1 (5.1) | 105 | 12.0 (4.9) | F(3.8,405)=5.7‡; P<0.0001; n=68, 71, 75 | F(2,282)=8.6; P<0.0001 | 0.40 | Not significant (P=0.34) | 0.17 | ||
| 6 months | 81 | 13.1 (4.6) | 83 | 12.6 (5.0) | 81 | 12.3 (5.0) | |||||||
| 12 months | 72 | 13.8 (4.8) | 73 | 12.5 (5.4) | 80 | 12.4 (5.0) | |||||||
| Baseline | 107 | 10.1 (4.8) | 105 | 10.3 (5.0) | 105 | 10.1 (4.4) | P=0.45; n=68, 70, 75 | — | — | — | — | ||
| 6 months | 81 | 11.3 (4.4) | 82 | 10.9 (4.5) | 82 | 10.6 (4.7) | |||||||
| 12 months | 72 | 11.9 (4.2) | 73 | 12.00 (4.6) | 78 | 11.1 (4.6) | |||||||
| Baseline | 107 | 9.0 (4.4) | 105 | 10.1 (5.4) | 104 | 9.7 (4.4) | P=0.21; n=69, 69, 75 | — | — | — | — | ||
| 6 months | 81 | 10.2 (4.4) | 84 | 10.0 (4.2) | 81 | 10.0 (4.4) | |||||||
| 12 months | 73 | 11.6 (4.5) | 71 | 10.6 (4.8) | 80 | 11.1 (4.1) | |||||||
| Baseline | 107 | 7.1 (3.1) | 105 | 7.8 (3.8) | 104 | 7.5 (2.8) | P=0.09‡; n=69, 73, 73 | — | — | — | — | ||
| 6 months | 81 | 8.0 (3.3) | 84 | 8.0 (3.8) | 82 | 7.5 (3.0) | |||||||
| 12 months | 73 | 9.0 (3.0) | 75 | 8.7 (3.8) | 78 | 8.3 (3.1) | |||||||
| Baseline | 107 | 6.7 (2.9) | 105 | 7.5 (3.5) | 104 | 7.2 (3.3) | F(3.6,382)=3.1‡; P=0.019; n=69, 70, 75 | — | — | — | — | ||
| 6 months | 81 | 7.8 (3.0) | 84 | 7.4 (3.6) | 82 | 7.1 (3.0) | |||||||
| 12 months | 73 | 8.7 (3.4) | 72 | 8.3 (3.4) | 80 | 8.1 (3.2) | |||||||
*Main effect time×intervention: F(df, error)=measure of variation between groups divided by variation within groups.
†No of participants in LiFE, structured exercise, and control groups, respectively.
‡Mauchley test of specificity significant, Greenhouse-Geisser reported.
Outcomes for secondary measures of function
| LiFE programme | Structured programme | Control programme | Comparison of all three groups* | Pairwise comparison of LiFE | Effect size | Pairwise comparison of structured | Effect size | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Mean score (standard deviation) | N | Mean score (standard deviation) | N | Mean score (standard deviation) | ||||||||
| Activities Specific Balance Confidence Scale | |||||||||||||
| Baseline | 106 | 1079 (283) | 105 | 1027 (272) | 105 | 1048 (328) | F(4,460)=3.75¶; P=0.005; n=75, 79, 79 | F(2,304)=5.52; P=0.004 | 0.38 | F(2,312)=5.22; P=0.006 | 0.37 | ||
| 6 months | 84 | 1228 (242) | 86 | 1144 (245) | 84 | 1112 (308) | |||||||
| 12 months | 79 | 1208 (275) | 80 | 1167 (268) | 82 | 1085 (302) | |||||||
| NHANES activities of daily life measure | |||||||||||||
| Baseline | 107 | 0.85 (0.46) | 105 | 0.93 (.49) | 105 | 0.91 (.51) | F(3.8,436)=4.74‡; P=0.001‡; n=75, 79, 80 | F(1.9,292)=11.32; P<0.0001 | 0.54 | Not significant (P=0.075) | 0.26 | ||
| 6 months | 83 | 0.67 (0.47) | 86 | 0.88 (.40) | 85 | 0.95 (.55) | |||||||
| 12 months | 79 | 0.74 (0.52) | 80 | 0.90 (.55) | 82 | 1.02 (.54) | |||||||
| Late life function index | |||||||||||||
| Baseline | 107 | 71.6 (11.8) | 104 | 69.5(12.6) | 104 | 69.2(14.8) | F(2,235)=9.13; P<0.0001; n=79, 78, 81 | F(1,158)=21.05; P<0.0001 | 0.73 | F(1,157)=6.66; P=0.04 | 0.41 | ||
| 12 months | 79 | 76.5 (14.3) | 79 | 71.9(12.9) | 82 | 68.3(15.8) | |||||||
| Late life disability index (frequency) | |||||||||||||
| Baseline | 107 | 56.7 (6.6) | 105 | 56.2 (8.1) | 105 | 55.5 (8.5) | F(2,236)=4.66; P=0.01; n=78, 80, 81 | F(1,157)=9.28; P=0.003 | 0.49 | Not significant (P=0.28) | 0.17 | ||
| 12 months | 78 | 58.4 (7.2) | 80 | 56.3 (8.4) | 81 | 54.8 (7.6) | |||||||
| Late life disability index (limitation) | |||||||||||||
| Baseline | 107 | 70.1 (8.7) | 105 | 69.4 (9.6) | 105 | 69.4 (9.9) | F(2,236)=1.17; P=0.31; n=78, 80, 81 | — | — | — | — | ||
| 12 months | 78 | 69.2 (11.9) | 80 | 67.5 (12.1) | 81 | 66.4 (11.1) | |||||||
| Physical activity scale for elderly | |||||||||||||
| Baseline | 107 | 66.1 (30.6) | 105 | 72.9 (38.8) | 105 | 64.4 (35.6) | F(3.7,432)=2.3‡; P=0.06§; n=76, 78, 80 | F(1.78,234)=3.28; P=0.045 | 0.29 | Not significant (P=0.88) | 0.05 | ||
| 6 months | 84 | 67.8 (36.8) | 86 | 61.0 (37.4) | 85 | 52.3 (26.8) | |||||||
| 12 months | 79 | 71.2 (40.9) | 79 | 63.2 (38.0) | 82 | 56.2 (36.7) | |||||||
*Main effect time×intervention; F(df,error)=measure of variation between groups divided by variation within groups; P value.
†No of participants in LiFE, structured exercise, and control groups, respectively.
‡Mauchley test of specificity significant, Greenhouse-Geisser reported.
§Retrospective Tukey analysis between LiFE and control groups, P=0.02.
¶Skewed data transformed before analysis.
Outcomes for other secondary measures
| LiFE programme | Structured programme | Control programme | Comparison of all three groups*† | Pairwise comparison of LiFE | Effect size | Pairwise comparison of structured | Effect Size | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Mean score (standard deviation) | N | Mean score (standard deviation) | N | Mean score (standard deviation) | |||||||||
| Baseline | 107 | 419 (651) | 104 | 429 (759) | 105 | 485 (786) | F(4,462)=7.15¶; P<0.0001; n=76, 78, 80 | F(2,308)=15.01; P<0.0001 | 0.62 | F(2,312)=4.85; P=0.008 | 0.36 | |||
| 6 months | 84 | 1083 (1261) | 86 | 824 (975) | 85 | 445 (652) | ||||||||
| 12 months | 79 | 1576 (1222) | 80 | 1009 (1116) | 82 | 660 (1025) | ||||||||
| Baseline | 107 | 67.3 (21.5) | 105 | 62.5 (20.4) | 105 | 60.8 (22.0) | F(3.8,436)=2.97‡; P=0.02 | — | — | — | — | |||
| 6 months | 84 | 68.3 (22.4) | 85 | 66.2 (23.7) | 85 | 59.2 (22.2) | ||||||||
| 12 months | 78 | 65.6 (24.8) | 81 | 58.7 (22.3) | 82 | 54.9 (20.9) | ||||||||
| Baseline | 107 | 7.1 (1.4) | 105 | 6.9 (1.5) | 105 | 7.0 (1.4) | F(3.89,452)=3.46‡; P=0.008§ | — | — | — | — | |||
| 6 months | 84 | 6.6 (1.3) | 86 | 6.9 (1.5) | 85 | 7.2 (1.6) | ||||||||
| 12 months | 79 | 6.7 (1.5) | 81 | 6.7 (1.6) | 82 | 6.7 (1.3) | ||||||||
| Baseline | 107 | 6.9 (1.7) | 105 | 7.2 (1.4) | 105 | 7.2 (1.6) | F(3.89,452)=3.36‡; P=0.01; n=76, 79, 80 | F(1.91,294)=4.46; P=0.01 | 0.34 | Not significant (P=0.87) | 0.06 | |||
| 6 months | 84 | 7.5 (1.4) | 86 | 7.4 (1.7) | 85 | 7.3 (1.7) | ||||||||
| 12 months | 79 | 7.7 (1.6) | 81 | 7.4 (1.5) | 82 | 7.5 (1.5) | ||||||||
| Baseline | 107 | 25.9 (4.8) | 105 | 26.6 (3.9) | 104 | 26.4 (4.2) | F(3.32,379)=4.8‡; P=0.002; n=74, 79, 78 | Not significant (P=0.26) | 0.08 | F(1.6,251)=7.7; P=0.001 | 0.45 | |||
| 6 months | 82 | 26.1 (5.1) | 86 | 26.6 (3.9) | 83 | 27.0 (4.1) | ||||||||
| 12 months | 79 | 26.3 (5.0) | 81 | 26.7(3.9) | 82 | 27.1 (4.4) | ||||||||
| Baseline | 90 | 47.4 (1.0) | 89 | 45.2 (1.1) | 85 | 46.1 (1.1) | F(4,348)=0.20; P=0.94; n=63, 54, 60 | — | — | — | — | |||
| 6 months | 72 | 46.5 (1.2) | 66 | 46.3 (1.4) | 69 | 46.5 (1.1) | ||||||||
| 12 months | 63 | 45.2 (1.1) | 64 | 46.1 (1.1) | 68 | 45.0 (1.3) | ||||||||
*Main effect time×intervention; F(df,error)=measure of variation between groups divided by variation within groups; P value.
†No of participants in LiFE, structured exercise, and control groups, respectively.
‡Mauchley test of specificity significant, Greenhouse-Geisser reported.
§Quadratic contrast significant, linear non-significant
¶Data were skewed, and therefore had to be transformed before analysis.
Analysis of variance for adherence to exercise programmes over first six months
| Programme | No of participants | Proportion (%) of adherence (mean (standard deviation)) | F ratio | P |
|---|---|---|---|---|
| LiFE | 107 | 47 (33) | 4.69 | 0.01 |
| Structured exercise | 105 | 35 (29) | ||
| Control | 105 | 47 (34) | ||
| Total | 317 | 43 (36) | — | — |
Exercise status over six months. Data are no (%) of participants
| LiFE programme (n=107) | Structured programme (n=105) | Control programme (n=105) | |
|---|---|---|---|
| Still exercising at end of six months | 81 (76) | 63 (60) | 74 (71) |
| Poor adherence (≤25%) in first six months | 7 (7) | 20 (19) | 12 (11) |
| Out of study or withdrawn from exercises | 19 (18) | 22 (21) | 19 (18) |